Trial of RA Drug Halted

(MedPage Today) -- Isis Pharmaceuticals is halting development of a new treatment for rheumatoid arthritis that targets the inflammatory marker C-reactive protein (CRP) for lack of clinical benefits, the company announced Monday. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/08/trial-of-ra-drug-halted.html